Colon CancerCoDIG-2NCT05943951
Italian Study on the Right Hemicolectomy: How the Lymphadenectomy is Performed
An observational study of Colon Cancer and Lymph Node Metastasis, run by Gabriele Anania at 62 sites in Italy.
Trial summary
The objective of the study is the analysis of lymphadenectomy in the course of right hemicolectomy, in relation to the radicality of the surgical resection that is performed. In particular, the investigators wants to inquire how according to precise standards regarding surgical radicalness and consequently the… Read more about this study
- Who is it for?
- Ages 18 to 95 years
- Conditions the study is for
- Colon Cancer, Lymph Node Metastasis, Surgical Procedure, Unspecified
- What is being tested?
- Right hemicolectomy
- Type of treatment
- Surgery or procedure
- How many people
- 788 participants
- Where
- 62 sitesItaly
- Study dates
- 1 Apr 2022to 30 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 95 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients aged > 18, men and women, operated by laparoscopic/robotic or video-assisted right hemicolectomy, under election regime with diagnosis of colic adenocarcinoma in one of the centers that take part of the study After the 6 months period a total of 788 patients was enrolled in the 76 italian centers
Who may be able to join
- Patients and/or legal guardians, where applicable, have been fully informed and have voluntarily provided informed written consent or patients unable to read and/or write who have fully understood the information verbally provided by the investigator and who have provided a verbal consent testified in writing by a third person.
- Patients aged > 18, men and women, operated by laparoscopic right hemiolectomy or video assisted, under election regime at the U.O. General and Thoracic Surgery with diagnosis of colic adenocarcinoma at any stage.
- Patients who have already undergone chemotherapy and radiotherapy for other reasons.
Who cannot join
- Under age.
- Patients undergoing emergency surgery.
- Women who are pregnant.
- Patients with right-handed laparotomy
Trial locations and contacts
62 sites in 1 country.
62 sites in 1 country
Italy62 sites
Ospedale Generale Regionale F. Miulli
Acquaviva delle Fonti, Bari
Ospedale Umberto I
Ancona
Ospedale Bonomo
Andria
Ospedale Regionale U. Parini
Aosta
Ospedale Santa Maria Annunziata
Bagno a Ripoli, Firenze
Policlinico Ponte San Pietro
Bergamo
ASL Biella
Biella
IRCCS AOU Bologna, Sant'Orsola
Bologna
Ospedale centrale di Bolzano
Bolzano
Ospedale San Pietro e Paolo
Borgosesia, Vercelli
Azienda Ospedaliero universitaria di Cagliari
Cagliari
PO Santissima Trinità ASL Cagliari
Cagliari
IRCCS Saverio de Bellis
Castellana Grotte, Bari
AOU Mater Domini Università Magna Grecia Catanzaro
Catanzaro
Ospedale San Paolo
Civitavecchia, Roma
Ospedale Valcamonica
Esine, Brescia
Anania Gabriele
Ferrara, 44124
AOU Careggi
Florence
Ospedale San Giovanni di Dio
Florence
Azienda Ospedaliero Universitaria di Foggia
Foggia
Ospedale Morgagni-Pierantoni
Forlì
Ospedale San Giovanni di Dio Frattamaggiore
Frattamaggiore, Napoli
Ospedale Carlo Urbani
Iesi, Ancona
Ospedale CTO
Iglesias, Sud Sardegna
P.O. San Salvatore
L’Aquila
Ospedale di Latisana
Latisana, Udine
Ospedale Nuovo di Legnano
Legnano, Milano
AO Papardo
Messina
IRCCS Ca Granada Ospedale Maggiore Policlinico Milano
Milan
Ospedale San Raffaele
Milan
AOU Modena
Modena
Ospedale San Valentino
Montebelluna, Treviso, 31044
ASST Spedali Civili
Montichiari, Brescia
AORN dei Colli - Ospedale Monaldi
Naples
AOU Federico II di Napoli
Naples
Isitituto Nazionale Tumori ICRSS Fondazione G. Pascale
Naples
Policlinico San Marco Zingonia
Osio Sotto, Bergamo
Policlinico P. Giaccone
Palermo
Ospedali Riuniti Marche Nord
Pesaro, 61121
Ospedale Civile Santo Spirito
Pescara
Ospedale Immacolata Concezione Piove di Sacco ULSS 6
Piove di Sacco, Padova
Azienda Ospedaliero Universitaria di Pisa
Pisa
Ospedale Santo Stefano
Prato
Ospedale civile di Macerata
Province of Macerata
AOU Tor Vergata
Roma
Azienda Ospedaliera Sant'Andrea
Roma
Ospedale San Carlo di Nancy
Roma
Ospedale San Filippo Neri ASL Roma 1
Roma
Ospedale Sandro Pertini
Roma
Ospedale Sant'Andrea
Roma
Policlinico Campus biomedico
Roma
Ospedale Santa Maria della Misericordia
Rovigo
Azienda Ospedaliero Universitaria Sassari
Sassari
Ospedale San Paolo
Savona
Ospedale Maria Vittoria
Torino
Ospedale Martini
Torino
Piccola casa della divina provenienza Ospedale Cottolengo
Torino
Ospedale Sant'Antonio Abate
Trapani
Ospedale San Camillo
Trento
AOU Trieste
Trieste
Ospedale Sant'andrea
Vercelli
Ospedale Belcolle
Viterbo
About this study
Official title: Lymphadenectomy in Right Hemicolectomy: Italian Multicenter Study (CoDIG-2)
The objective of the study is the analysis of lymphadenectomy in the course of right hemicolectomy, in relation to the radicality of the surgical resection that is performed. In particular, the investigators wants to inquire how according to precise standards regarding surgical radicalness and consequently the anatomical piece that is obtained it is possible to correlate a certain number of lymph nodes and their possible positivity.
The lead center is the General and Thoracic Surgery Department of the University of Ferrara. Prof. Anania is the responsible for the enrollment of patients and the coordination with the collaborating centers in the six month-study
Read the detailed description
All the high-volume specialist centres that perform this type of intervention in Italy will be invited, with a minimum number of 25 interventions per year. At the end of the study 788 patients was enrolled.
The data of the patients involved will be collected independently and anonymously by the individual centers involved, using a common alpha numeric code decided by the coordinating center.
The parameters examined will be:
- Personal data of the patient
- Stage of neoplasm due to surgery
- Type of surgery and duration
- Post-operative course
- Presence of post-surgical complications and eventual hospital readmission due to these complications
- Study of the operating piece and lymphadenectomy performed:
Tumor free margin Terminal ilium length The different vascular ligatures and levels at which they are performed Integrity of the mesocolon Number of positive nodes per total removed
Following the end of the 6 months of observational study period, the data will be processed anonymously at the coordinating centre.
- Being tested
- Right hemicolectomy
- Keywords
- Right hemicolectomy, Colon cancer, Lymphadenectomy
- Medical subject headings
- Colonic Neoplasms, Lymphatic Metastasis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Right hemicolectomyProcedure or surgery
It begins with a thorough laparoscopic inspection of the abdomen for evidence of metastatic disease and to confirm the location of the tumor. Usually is performed dissection using a medial-to-lateral approach. A lateral or inferior approach can also be used depending on the anatomy. The vascular dissection may begin at the ileocolic pedicle or over the superiore mesenteric vein. After completing the medial-to-lateral dissection, the sourgeons return to the ileocolic pedicle to begin vascular dissection. Whether a D2 (until encountering the right branch of the middle colic) or D3 dissection (until the root of ileocolic artery and vein) is performed depends upon the tumor stage. For an intracorporeal anastomosis, the bowel is transected proximally and distally using a linear stapler. The terminal ileum is positioned along the transverse colon in an isoperistaltic fashion. After that a colotomy and an enterotomy are made on the antimesenteric edge of the colon and small bowel respectively
What is being measured
The primary outcome is the main question the study is designed to answer.
the analysis of lymphadenectomy in the course of right hemciolectomy, in relation to the radicality of surgical resection that is performed
In particular, the invastigators want to inquire how according to precise standards regarding surgical radicalness and consequently the anatomical piece that is obtained it is possible to correlate a certain number of lymph nodes and their possible positivity. In the study various items about lymphadenectomy will be invastigated: tumor free margin > 5cm, lenght of teminal ileum > 10cm, different level at which colic vessel are closed (proximal or distal ligation) and consequentially the different lymph nodes stations collected, mesocolic sail integrity based on Benz score, number of lymph node harvest and number of lymph nodes positive for metastatic involvement, type of surgical procedure (video-assisted, laparoscopic, robotic).
Measured: 6 months
Secondary outcomes (1)
Vascular anatomical variability
The investigators wants to study the vascular anatomical variability of the patients enrolled in the study, and how this variability may affect the extent of lymphoadenectomy. The investigators will analize the vessels anatomy with pre-operative imaging (CT scan) and with intra-operative feedback. The attention will be on the position of superior mesenteric artery relative to superior mesenteric vein (before or behind). Futhermore the invastigators wants to study the anatomical variants of the vessels: the presence of the middle colic artery and its branches, the presence of the right colic artery and their variability in percentage terms
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jul 2023
- Study start1 Apr 2022
- Primary completion30 Sep 2022
- Study completion30 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Colon CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 788 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gabriele Anania
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Gabriele Anania, University Hospital of Ferrara
- Investigators
- Gabriele Anania, Principal investigator, Ferrara University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05943951
- Sponsor's protocol ID
- CoDIG-2
- Acronym
- CoDIG-2
- Status last verified
- Jul 2023
- First submitted
- 27 Jun 2023
- Last updated
- 13 Jul 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: privacy
Publications
Anania G, Chiozza M, Campagnaro A, Bagolini F, Resta G, Azzolina D, Silecchia G, Cirocchi R, Agrusa A, Cuccurullo D, Guerrieri M; SICE CoDIG (ColonDx Italian Group). Laparoscopic right hemicolectomy: a SICE (Societa Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?-CoDIG 2 (ColonDx Italian Group). Surg Endosc. 2024 Mar;38(3):1432-1441. doi: 10.1007/s00464-023-10607-8. Epub 2024 Jan 8.
PubMed 38191814
Study at a glance
From the registry record, last updated by the sponsor on 13 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Lymphadenectomy in Right Hemicolectomy: Italian Multicenter Study (CoDIG-2)
- ClinicalTrials.gov ID
- NCT05943951
- Acronym / sponsor ID
- CoDIG-2 / CoDIG-2
- Keywords
- Right hemicolectomy, Colon cancer, Lymphadenectomy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 788 participants (actual)
- Lead sponsor
- Gabriele AnaniaUniversity, hospital or other
- Study start
- 1 Apr 2022 (actual)
- Primary completion
- 30 Sep 2022 (actual)
- Study completion
- 30 Oct 2022 (actual)
- First posted
- 13 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of the study is the analysis of lymphadenectomy in the course of right hemicolectomy, in relation to the radicality of the surgical resection that is performed. In particular, the investigators wants to inquire how according to precise standards regarding surgical radicalness and consequently the anatomical piece that is obtained it is possible to correlate a certain number of lymph nodes and their possible positivity.
The lead center is the General and Thoracic Surgery Department of the University of Ferrara. Prof. Anania is the responsible for the enrollment of patients and the coordination with the collaborating centers in the six month-study
Detailed description
All the high-volume specialist centres that perform this type of intervention in Italy will be invited, with a minimum number of 25 interventions per year. At the end of the study 788 patients was enrolled.
The data of the patients involved will be collected independently and anonymously by the individual centers involved, using a common alpha numeric code decided by the coordinating center.
The parameters examined will be:
- Personal data of the patient
- Stage of neoplasm due to surgery
- Type of surgery and duration
- Post-operative course
- Presence of post-surgical complications and eventual hospital readmission due to these complications
- Study of the operating piece and lymphadenectomy performed:
Tumor free margin Terminal ilium length The different vascular ligatures and levels at which they are performed Integrity of the mesocolon Number of positive nodes per total removed
Following the end of the 6 months of observational study period, the data will be processed anonymously at the coordinating centre.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 95 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients aged > 18, men and women, operated by laparoscopic/robotic or video-assisted right hemicolectomy, under election regime with diagnosis of colic adenocarcinoma in one of the centers that take part of the study After the 6 months period a total of 788 patients was enrolled in the 76 italian centers
Key inclusion criteria (3 listed)
- Patients and/or legal guardians, where applicable, have been fully informed and have voluntarily provided informed written consent or patients unable to read and/or write who have fully understood the information verbally provided by the investigator and who have provided a verbal consent testified in writing by a third person.
Key exclusion criteria (4 listed)
- Under age.
- Patients undergoing emergency surgery.
- Women who are pregnant.
- Patients with right-handed laparotomy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Right hemicolectomyIt begins with a thorough laparoscopic inspection of the abdomen for evidence of metastatic disease and to confirm the location of the tumor. Usually is performed dissection using a medial-to-lateral approach. A lateral or inferior approach can also be used depending on the anatomy. The vascular dissection may begin at the ileocolic pedicle or over the superiore mesenteric vein. After completing the medial-to-lateral dissection, the sourgeons return to the ileocolic pedicle to begin vascular dissection. Whether a D2 (until encountering the right branch of the middle colic) or D3 dissection (until the root of ileocolic artery and vein) is performed depends upon the tumor stage. For an intracorporeal anastomosis, the bowel is transected proximally and distally using a linear stapler. The terminal ileum is positioned along the transverse colon in an isoperistaltic fashion. After that a colotomy and an enterotomy are made on the antimesenteric edge of the colon and small bowel respectively | Procedure or surgery | – |
Primary outcome
the analysis of lymphadenectomy in the course of right hemciolectomy, in relation to the radicality of surgical resection that is performed
Time frame: 6 months
In particular, the invastigators want to inquire how according to precise standards regarding surgical radicalness and consequently the anatomical piece that is obtained it is possible to correlate a certain number of lymph nodes and their possible positivity. In the study various items about lymphadenectomy will be invastigated: tumor free margin > 5cm, lenght of teminal ileum > 10cm, different level at which colic vessel are closed (proximal or distal ligation) and consequentially the different lymph nodes stations collected, mesocolic sail integrity based on Benz score, number of lymph node harvest and number of lymph nodes positive for metastatic involvement, type of surgical procedure (video-assisted, laparoscopic, robotic).
1 secondary outcome
Vascular anatomical variability
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jul 2023.
- Derived from this study: PubMed 38191814Anania G, Chiozza M, Campagnaro A, Bagolini F, Resta G, Azzolina D, Silecchia G, Cirocchi R, Agrusa A, Cuccurullo D, Guerrieri M; SICE CoDIG (ColonDx Italian Group). Laparoscopic right hemicolectomy: a SICE (Societa Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?-CoDIG 2 (ColonDx Italian Group). Surg Endosc. 2024 Mar;38(3):1432-1441. doi: 10.1007/s00464-023-10607-8. Epub 2024 Jan 8.
- Individual participant dataSharing planned: No. privacy
Related trials for Colon Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gabriele Anania principal investigator
Ferrara University Hospital
62 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colon Cancer and Lymph Node Metastasis, run by Gabriele Anania at 62 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 62 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the analysis of lymphadenectomy in the course of right hemciolectomy, in relation to the radicality of surgical resection that is performed (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05943951, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2023.